The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine

E-ISSN： 1873-5592|18|4|447-454

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.4, 2017-02, pp. : 447-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 208-219

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting YAP and Hippo signaling pathway in liver cancer

By Liu Angela M Xu Michelle Z Chen Jinfei Poon Ronnie T Luk John M

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 8, 2010-08 ,pp. : 855-868

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Hippo Pathway for Anti-cancer Therapies

Current Medicinal Chemistry, Vol. 22, Iss. 35, 2015-11 ,pp. : 4104-4117

Bentham Science Publishers

Access to resources Recommend Favorite

The Hedgehog signaling pathway – implications for drug targets in cancer and neurodegenerative disorders

By Bak Mads Hansen Claus Tommerup Niels Larsen Lars Allan

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 411-429

Future Medicine

Access to resources Recommend Favorite

Wnt / &bgr;-Catenin Signaling Pathway as Novel Cancer Drug Targets

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 653-671

Bentham Science Publishers

Access to resources Recommend Favorite